Main Article Content



In 90% cases of breast cancer (BrCa), the most important cause of death due to cancer is metastatic disease. This review was conducted with the aim of illuminating our understanding of the role of exosomes in the process of metastasis in breast cancer. The mechanisms of metastasis are fundamentally multifaceted, with different distant sites having a specific extracellular matrix and cellular composition favourable for metastasis and very different in characters compared to the primary site. Systemic spread of cancer cells can happen early in breast cancer even before the detection of the primary tumour. The distant organ(s) is preconditioned to receive (seed) the tumour cells in circulation. The preparation is done by exosomes which carry different types of protein, lipids and nucleic acids which on fusing with the metastatic site’s tissues’ cells alter the microenvironment and make it conducive for metastatic cancerous cells to colonize. Tumour-derived exosomes (TEX) contents and numbers vary depending on current physiological or pathological conditions. The role of these TEXs is crucial in the steps of metastatic spread of a primary tumour, extending from reprogramming of primary malignant cells, to the preparation of pre-metastatic niches and to the final implanting of adjacent and distant sites. There is detachment of the cancer cells from the primary tumour site and migration into blood vessels and lymphatics followed by movement of cancer cell from circulation into a different tissue.  The seeded cancerous cells can remain in dormancy till the internal homeostasis is maintained. When that is disrupted then there is development of micro metastasis and macro metastasis. All these processes mediated by exosomes are discussed in this paper.

Exosomal, breast carcinoma, spread, mediation, intravasation, extravasation, latency, micrometastasis, macrometastasis

Article Details

How to Cite
SAHU, S., AUGUSTHY, A., & JAWALEKAR, S. L. (2020). HOW DO THE TUMOUR DERIVED EXOSOMES MEDIATE BREAST CANCER METASTASIS? - A NARRATIVE REVIEW. Journal of Biochemistry International, 7(1), 19-24. Retrieved from
Review Article


Madhav MR, Nayagam SG, Biyani K, Pandey V, Kamal DG, Sabarimurugan S, et al. Epidemiologic analysis of breast cancer incidence, prevalence, and mortality in India: Protocol for a systematic review and meta-analyses. Medicine (Baltimore). 2018;97(52): e13680.

Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol. 2017;13(4): 289–95.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet Lond Engl. 2018;391(10125):1023–75.

Tian W, Liu S, Li B. Potential Role of Exosomes in Cancer Metastasis. BioMed Res Int. 2019;4649705.

Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, Hall JA, et al. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol. 2019;16(3):185–204.

Fidler IJ, Kripke ML. The challenge of targeting metastasis. Cancer Metastasis Rev. 2015;34(4):635–41.

Spano D, Heck C, De Antonellis P, Christofori G, Zollo M. Molecular networks that regulate cancer metastasis. Semin Cancer Biol. 2012; 22(3):234–49.

Valastyan S, Weinberg RA. Tumor metastasis: Molecular insights and evolving paradigms. Cell. 2011;147(2):275–92.

Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13(1):58–68.

Weinberg RA. Leaving home early: reexamination of the canonical models of tumor progression. Cancer Cell. 2008;14(4): 283–4.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5): 646–74.

Moon PG, Lee JE, Cho YE, Lee SJ, Chae YS, Jung JH, et al. Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer. Oncotarget. 2016;7(26): 40189–99.

Akhtar M, Haider A, Rashid S, Al-Nabet ADMH. Paget’s “Seed and Soil” theory of cancer metastasis: An idea whose time has come. Adv Anat Pathol. 2019;26(1):69–74.

Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med [Internet]. 2012;18(6):883–91.

[Cited 2018 Dec 3]


Li K, Chen Y, Li A, Tan C, Liu X. Exosomes play roles in sequential processes of tumor metastasis. Int J Cancer. 2019;144(7):1486–95.

Wang M, Ji S, Shao G, Zhang J, Zhao K, Wang Z, et al. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2018;20(7): 906–11.

Wang J, Wu Y, Guo J, Fei X, Yu L, Ma S. Adipocyte-derived exosomes promote lung cancer metastasis by increasing MMP9 activity via transferring MMP3 to lung cancer cells. Oncotarget. 2017;8(47):81880–91.

Pinilla S, Alt E, Abdul Khalek FJ, Jotzu C, Muehlberg F, Beckmann C, et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. 2009; 284(1):80–5.

Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, et al. Pre-metastatic niches: Organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302–17.

Psaila B, Lyden D. The metastatic niche: Adapting the foreign soil. Nat Rev Cancer. 2009;9(4):285–93.

Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820–7.

Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9(4):239–52.

Seubert B, Grünwald B, Kobuch J, Cui H, Schelter F, Schaten S, et al. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatol Baltim Md. 2015;61(1):238–48.

Cox TR, Rumney RMH, Schoof EM, Perryman L, Høye AM, Agrawal A, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015;522(7554):106–10.

Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol. 2015;17(2):183–94.

Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015; 15(2):96–109.

Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015; 527(7578):329–35.

Ginsberg MH, Partridge A, Shattil SJ. Integrin regulation. Curr Opin Cell Biol. 2005;17(5): 509–16.

Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9(1):191.

Wang L, Wang J. MicroRNA-mediated breast cancer metastasis: From primary site to distant organs. Oncogene. 2012;31(20):2499–511.

van Es N, Sturk A, Middeldorp S, Nieuwland R. Effects of cancer on platelets. Semin Oncol. 2014;41(3):311–8.